Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GH Research PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GHRS
Nasdaq
2834
www.ghres.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GH Research PLC
GHRS Stock Rallies 55% in a Week: Here's What You Should Know
- Feb 6th, 2025 3:25 pm
GH Research Announces Pricing of $150 Million Public Offering
- Feb 5th, 2025 1:52 am
Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025
- Feb 4th, 2025 1:22 am
GH Research Announces Proposed Public Offering
- Feb 3rd, 2025 9:03 pm
Shares of psychedelics biotech nearly double on depression data
- Feb 3rd, 2025 12:07 pm
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
- Feb 3rd, 2025 12:00 pm
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
- Jan 31st, 2025 9:01 pm
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
- Jan 10th, 2025 12:00 pm
Does GH Research (GHRS) Have the Potential to Rally 225.18% as Wall Street Analysts Expect?
- Nov 20th, 2024 2:55 pm
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
- Nov 18th, 2024 12:19 pm
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Nov 14th, 2024 12:00 pm
We Think GH Research (NASDAQ:GHRS) Can Afford To Drive Business Growth
- Nov 10th, 2024 12:06 pm
GH Research (GHRS) Moves to Buy: Rationale Behind the Upgrade
- Sep 9th, 2024 4:00 pm
After Plunging -18.19% in 4 Weeks, Here's Why the Trend Might Reverse for GH Research (GHRS)
- Sep 9th, 2024 1:35 pm
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Sep 3rd, 2024 11:05 am
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
- Sep 3rd, 2024 11:00 am
3 Psychedelic Stocks to Ride to the Moon and Beyond
- Jul 6th, 2024 11:21 am
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
- Jul 3rd, 2024 1:48 pm
GH Research (NASDAQ:GHRS) Is In A Good Position To Deliver On Growth Plans
- Jun 2nd, 2024 12:33 pm
Recent Price Trend in GH Research (GHRS) is Your Friend, Here's Why
- May 13th, 2024 12:50 pm
Scroll